» Articles » PMID: 23183179

Hydrogen Sulfide Impairs Glucose Utilization and Increases Gluconeogenesis in Hepatocytes

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2012 Nov 28
PMID 23183179
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Mounting evidence has established hydrogen sulfide (H(2)S) as an important gasotransmitter with multifaceted physiological functions. The aim of the present study was to investigate the role of H(2)S on glucose utilization, glycogen synthesis, as well as gluconeogenesis in both HepG(2) cells and primary mouse hepatocytes. Incubation with NaHS (a H(2)S donor) impaired glucose uptake and glycogen storage in HepG(2) cells via decreasing glucokinase activity. Adenovirus-mediated cystathionine γ-lyase (CSE) overexpression increased endogenous H(2)S production and lowered glycogen content in HepG(2) cells. Glycogen content was significantly higher in liver tissues from CSE knockout (KO) mice compared to that from wild type (WT) mice in fed condition. Glucose consumption was less in primarily cultured hepatocytes isolated from WT mice than those from CSE KO mice, but more glucose was produced by hepatocytes via gluconeogenesis and glycogenolysis pathways in WT mice than in CSE KO mice. NaHS treatment reduced the phosphorylation of AMP-activated protein kinase, whereas stimulation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside reversed H(2)S-impaired glucose uptake. H(2)S-increased glucose production was likely through increased phosphoenolpyruvate carboxykinase activity. In addition, insulin at the physiological range inhibited CSE expression, and H(2)S decreased insulin-stimulated phosphorylation of Akt in HepG(2) cells. CSE expression was increased, however, in insulin-resistant state induced by exposing cells to high levels of insulin (500 nm) and glucose (33 mm) for 24 h. Taken together, these data suggest that the interaction of H(2)S and insulin in liver plays a pivotal role in regulating insulin sensitivity and glucose metabolism.

Citing Articles

Gut-X axis.

Lin X, Yu Z, Liu Y, Li C, Hu H, Hu J Imeta. 2025; 4(1):e270.

PMID: 40027477 PMC: 11865426. DOI: 10.1002/imt2.270.


The Gut Microbiota-Related Antihyperglycemic Effect of Metformin.

Szymczak-Pajor I, Drzewoski J, Kozlowska M, Krekora J, Sliwinska A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861118 PMC: 11768994. DOI: 10.3390/ph18010055.


Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response.

Kirtipal N, Seo Y, Son J, Lee S Diabetes Metab J. 2024; 48(5):821-836.

PMID: 39313228 PMC: 11449821. DOI: 10.4093/dmj.2024.0382.


Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus.

Al-Busaidi A, Alabri O, Alomairi J, ElSharaawy A, Al Lawati A, Al Lawati H Curr Diabetes Rev. 2024; 21(1):e170124225723.

PMID: 38243954 DOI: 10.2174/0115733998281910231231051814.


HS- and Redox-State-Mediated PTP1B S-Sulfhydration in Insulin Signaling.

Lin Y, Zeng W, Lee D Int J Mol Sci. 2023; 24(3).

PMID: 36769221 PMC: 9917502. DOI: 10.3390/ijms24032898.